Filing Flows › LifeMD (LFMD) › Q1 2026 › vs Q4 2025
LifeMD (LFMD) Q1 2026 vs Q4 2025 (quarter over quarter)
LifeMD's revenue rose $43.1M (+609%) from $7.1M in Q4 2025 to $50.2M in Q1 2026.
LifeMD, Q1 2026: revenue $50.2M (-1% year over year), operating margin -17.8%, net loss $8.9M, operating cash flow $445K. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $50.2M | $7.1M | $43.1M | +609% |
| Net loss | $8.9M | −$19.9M | $28.8M | — |
| Costs & expenses | $59.1M | $33.2M | $25.8M | +78% |
| Operating costs | $59.1M | $13.3M | $45.8M | +344% |
| Cost of revenue | $5.9M | $4.2M | $1.7M | +40% |
| General & admin | $15.2M | $6.7M | $8.4M | +126% |
| Other operating costs | $8.1M | $2.3M | $5.8M | +246% |
| Operating cash sources | $9.3M | −$23.2M | $32.5M | — |
| Depreciation & amortization | $321K | $0 | $321K | — |
| Share-based compensation | $1.4M | $2.7M | −$1.2M | -45% |
| Working capital & other | $7.5M | −$25.9M | $33.4M | — |
| Net loss absorbed | $8.9M | −$19.9M | $28.8M | — |
| Operating cash flow | $445K | −$3.3M | $3.7M | — |
| Capital expenditures | $2.0M | $155K | $1.8M | 13× |
| Negative free cash flow (OCF − capex) | $1.6M | $3.4M | −$1.9M | -55% |
Questions
How much did LifeMD's revenue grow quarter over quarter in Q1 2026?
LifeMD's revenue rose $43.1M (+609%) from $7.1M in Q4 2025 to $50.2M in Q1 2026.